Company profile BFRI

Biofrontera Inc
biofrontera pharma gmbh is a pharmaceuticals company based out of 104 waldhofer straße, heidelberg, bw, germany.
Quarter analysis & expected interest

There is not enough data for Biofrontera Inc. to provide analysis

Correlation between past revenue and Biofrontera Inc. search interest

There is not enough data for Biofrontera Inc. to provide correlation calculation

Analysis of YoY 5Y Google Trends

There is not enough data for Biofrontera Inc. to provide analysis

Google Trends widget for keyword preview might not work in your browser. If so, try Google Chrome
Quarter analysis & expected interestLast update: November 04 2023 02:29:35.

After 34 days of this quarter the interest is at 117.0. Based on that we can calculate that during remaining 58 days it will total up to 317.0.
Ameluz expected interest is significantly higher compared to previous quarter (+340.3%) and same quarter last year (+138.3%).

YearQ1Q2Q3Q4
2018 - - - 137
2019 187
36.5% QoQ
181
-3.2% QoQ
174
-3.9% QoQ
160
16.8% YoY -8.0% QoQ
2020 153
-18.2% YoY -4.4% QoQ
168
-7.2% YoY 9.8% QoQ
205
17.8% YoY 22.0% QoQ
123
-23.1% YoY -40.0% QoQ
2021 62
-59.5% YoY -49.6% QoQ
234
39.3% YoY 277.4% QoQ
179
-12.7% YoY -23.5% QoQ
190
54.5% YoY 6.1% QoQ
2022 85
37.1% YoY -55.3% QoQ
198
-15.4% YoY 132.9% QoQ
98
-45.3% YoY -50.5% QoQ
133
-30.0% YoY 35.7% QoQ
2023 298
250.6% YoY 124.1% QoQ
186
-6.1% YoY -37.6% QoQ
72
-26.5% YoY -61.3% QoQ
117
-12.0% YoY 62.5% QoQ
this symbol represents interest this quarter up to now and updates daily. For expected interest by the end of the quarter based on current trend see "Quarter analysis" above the table.
Correlation between past revenue and Ameluz search interestLast update: November 04 2023 02:29:35.
Correlation coefficient between keyword and revenue is -0.01
Interest value is multiplied to fit the chart properly. Correlation level is represented by Pearson correlation coefficient. Value closer to 1 represents higher level of correlation. Value closer to -1 represents inverted relationship. Value closer to 0 represents no relationship.
Analysis of YoY 5Y Google Trends Last update: November 04 2023 02:29:35.

The average 5 years interest of Ameluz was 12.8 per week.
The last year interest of Ameluz compared to the last 5 years has changed by 21.09%.
This is something to be checked.
The last year interest is comparable to 5 years ago. It has changed only by 11.67%.

Google Trends widget for keyword preview might not work in your browser. If so, try Google Chrome
Quarter analysis & expected interest

There is not enough data for RhodoLED lamp to provide analysis

Correlation between past revenue and RhodoLED lamp search interest

There is not enough data for RhodoLED lamp to provide correlation calculation

Analysis of YoY 5Y Google Trends

There is not enough data for RhodoLED lamp to provide analysis

Google Trends widget for keyword preview might not work in your browser. If so, try Google Chrome
Quarter analysis & expected interestLast update: November 04 2023 02:30:13.

After 34 days of this quarter the interest is at 0.0. Based on that we can calculate that during remaining 58 days it will total up to 0.0.
That appears to be equal to previous quarter and same quarter last year.

YearQ1Q2Q3Q4
2018 - - - 193
2019 454
135.2% QoQ
299
-34.1% QoQ
291
-2.7% QoQ
217
12.4% YoY -25.4% QoQ
2020 83
-81.7% YoY -61.8% QoQ
210
-29.8% YoY 153.0% QoQ
190
-34.7% YoY -9.5% QoQ
118
-45.6% YoY -37.9% QoQ
2021 166
100.0% YoY 40.7% QoQ
241
14.8% YoY 45.2% QoQ
88
-53.7% YoY -63.5% QoQ
35
-70.3% YoY -60.2% QoQ
2022 122
-26.5% YoY 248.6% QoQ
0
-100.0% YoY -100.0% QoQ
0
-100.0% YoY -100.0% QoQ
0
-100.0% YoY -100.0% QoQ
2023 0
-100.0% YoY -100.0% QoQ
0
-100.0% YoY -100.0% QoQ
0
-100.0% YoY -100.0% QoQ
0
-100.0% YoY -100.0% QoQ
this symbol represents interest this quarter up to now and updates daily. For expected interest by the end of the quarter based on current trend see "Quarter analysis" above the table.
Correlation between past revenue and Xepi search interestLast update: November 04 2023 02:30:13.
Correlation coefficient between keyword and revenue is 0.18
Interest value is multiplied to fit the chart properly. Correlation level is represented by Pearson correlation coefficient. Value closer to 1 represents higher level of correlation. Value closer to -1 represents inverted relationship. Value closer to 0 represents no relationship.
Analysis of YoY 5Y Google Trends Last update: November 04 2023 02:30:15.

The average 5 years interest of Xepi was 10.37 per week.
The last year interest of Xepi compared to the last 5 years has changed by -100.0%.
This is something to be checked.
The last year interest is quite lower compared to 5 years ago. It has decreased by -100.0%.

Google Trends widget for keyword preview might not work in your browser. If so, try Google Chrome
Quarter analysis & expected interest

There is not enough data for Biofrontera careers to provide analysis

Correlation between past revenue and Biofrontera careers search interest

There is not enough data for Biofrontera careers to provide correlation calculation

Analysis of YoY 5Y Google Trends

There is not enough data for Biofrontera careers to provide analysis

Google Trends widget for keyword preview might not work in your browser. If so, try Google Chrome
Quarter analysis & expected interest

There is not enough data for Biofrontera reviews to provide analysis

Correlation between past revenue and Biofrontera reviews search interest

There is not enough data for Biofrontera reviews to provide correlation calculation

Analysis of YoY 5Y Google Trends

There is not enough data for Biofrontera reviews to provide analysis

Google Trends widget for keyword preview might not work in your browser. If so, try Google Chrome
Quarter analysis & expected interest

There is not enough data for Biofrontera dermatology to provide analysis

Correlation between past revenue and Biofrontera dermatology search interest

There is not enough data for Biofrontera dermatology to provide correlation calculation

Analysis of YoY 5Y Google Trends

There is not enough data for Biofrontera dermatology to provide analysis

Google Trends widget for keyword preview might not work in your browser. If so, try Google Chrome
Quarter analysis & expected interestLast update: November 04 2023 02:30:46.

After 34 days of this quarter the interest is at 15.0. Based on that we can calculate that during remaining 58 days it will total up to 41.0.
Biofrontera -stock -company expected interest is significantly higher compared to same quarter last year (+78.3%) but similar to previous quarter.

YearQ1Q2Q3Q4
2018 - - - 4
2019 11
175.0% QoQ
32
190.9% QoQ
24
-25.0% QoQ
13
225.0% YoY -45.8% QoQ
2020 50
354.5% YoY 284.6% QoQ
25
-21.9% YoY -50.0% QoQ
194
708.3% YoY 676.0% QoQ
13
0.0% YoY -93.3% QoQ
2021 13
-74.0% YoY 0.0% QoQ
15
-40.0% YoY 15.4% QoQ
13
-93.3% YoY -13.3% QoQ
91
600.0% YoY 600.0% QoQ
2022 44
238.5% YoY -51.6% QoQ
15
0.0% YoY -65.9% QoQ
20
53.8% YoY 33.3% QoQ
23
-74.7% YoY 15.0% QoQ
2023 23
-47.7% YoY 0.0% QoQ
20
33.3% YoY -13.0% QoQ
38
90.0% YoY 90.0% QoQ
15
-34.8% YoY -60.5% QoQ
this symbol represents interest this quarter up to now and updates daily. For expected interest by the end of the quarter based on current trend see "Quarter analysis" above the table.
Correlation between past revenue and Biofrontera -stock -company search interestLast update: November 04 2023 02:30:45.
Correlation coefficient between keyword and revenue is 0.55
Interest value is multiplied to fit the chart properly. Correlation level is represented by Pearson correlation coefficient. Value closer to 1 represents higher level of correlation. Value closer to -1 represents inverted relationship. Value closer to 0 represents no relationship.
Analysis of YoY 5Y Google Trends Last update: November 04 2023 02:30:46.

The average 5 years interest of Biofrontera -stock -company was 2.67 per week.
The last year interest of Biofrontera -stock -company compared to the last 5 years has changed by -25.84%.
This is something to be checked.
The last year interest is quite higher compared to 5 years ago. It has increased by 39.44%.

Google Trends widget for keyword preview might not work in your browser. If so, try Google Chrome
Quarter analysis & expected interest

There is not enough data for Biofrontera alternative treatments to provide analysis

Correlation between past revenue and Biofrontera alternative treatments search interest

There is not enough data for Biofrontera alternative treatments to provide correlation calculation

Analysis of YoY 5Y Google Trends

There is not enough data for Biofrontera alternative treatments to provide analysis

Google Trends widget for keyword preview might not work in your browser. If so, try Google Chrome
Quarter analysis & expected interest

There is not enough data for Biofrontera - FDA approval to provide analysis

Correlation between past revenue and Biofrontera - FDA approval search interest

There is not enough data for Biofrontera - FDA approval to provide correlation calculation

Analysis of YoY 5Y Google Trends

There is not enough data for Biofrontera - FDA approval to provide analysis

Google Trends widget for keyword preview might not work in your browser. If so, try Google Chrome
Useful links and data for BFRI
Earnings date: 2024-03-06 After close
Company name: Biofrontera Inc
Sector: Manufacturing
Company's website
Hypercharts
Yahoo Finance
MarketWatch
StockTwits
SEC Filings
SwaggyStocks
Latest articles

2026-05-14T11:30:00Z

GlobeNewswire
Biofrontera Inc. Reports First Quarter 2026 Financial Results and Provides a Business Update

2026-05-13T13:00:00Z

GlobeNewswire
Biofrontera Launches Second Annual "Hats On" Campaign to Raise Awareness of Actinic Keratosis

2026-05-08T20:00:00Z

GlobeNewswire
Biofrontera Inc. to Report First Quarter 2026 Financial Results and Host a Conference Call on May 14, 2026

2026-03-09T21:25:00Z

GlobeNewswire
Biofrontera Inc. to Report Fourth Quarter and Full Year 2025 Financial Results and Host a Conference Call on March 19, 2026

2026-03-09T13:15:00Z

GlobeNewswire
Biofrontera Inc. Reports Positive Phase 2b Results Supporting Further Development of Ameluz® Photodynamic Therapy for moderate to severe Acne Vulgaris

2026-02-26T14:15:00Z

GlobeNewswire
U.S. Patent Office Issues Final Written Decision Finding All Challenged Claims of Sun Pharma's Patent 11,697,028 To Be Unpatentable

2026-02-17T14:15:00Z

GlobeNewswire
Biofrontera Inc. Announces Database Lock of Phase 1 Pharmacokinetics Study of Ameluz® for Actinic Keratoses on Trunk and Extremities

2026-02-11T14:15:00Z

GlobeNewswire
Biofrontera Announces FDA Filing Acceptance of Supplemental New Drug Application for Ameluz® PDT in Superficial Basal Cell Carcinoma

2026-02-09T14:15:00Z

GlobeNewswire
Biofrontera Announces Positive Results in Phase 3 Study of Ameluz® PDT for Actinic Keratoses on the Extremities, Neck, and Trunk, Meeting Primary Endpoint

2026-01-13T13:30:00Z

GlobeNewswire
Biofrontera Inc. Announces Record Preliminary Fourth Quarter 2025 Revenues between $17.0 Million and $17.5 Million, Representing Approximately 35% Year-Over-Year Growth

2026-01-08T13:45:00Z

GlobeNewswire
Biofrontera Inc. Announces Data Base Locks for Two Clinical Studies Supporting Key Data and Regulatory Milestones

2025-12-18T13:45:00Z

GlobeNewswire
Biofrontera Inc. Completes Transfer of Ameluz® and RhodoLED® FDA approval and Associated Intellectual Property Portfolio

2025-12-04T14:00:00Z

GlobeNewswire
Last Patient Completes Biofrontera's Phase 1 Pharmacokinetics Study of Ameluz® for Treatment of Actinic Keratoses on the Trunk and Extremities

2025-12-02T13:45:00Z

GlobeNewswire
Biofrontera Inc. Announces Filing of Supplemental New Drug Application (sNDA) for the Treatment of Superficial Basal Cell Carcinoma (sBCC) with Ameluz®-PDT

2025-11-13T13:15:00Z

GlobeNewswire
Biofrontera Inc. Reports Third Quarter 2025 Financial Results and Provides a Business Update